(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

Baxter 2B1357X - 0.45% Sodium Chloride and 20 mEq/L Potassium Chloride Injection, USP, 1000 ml, Viaflex Plastic Container, 14/cs (Rx) (Continental US Only, Excluding IN and ND)

Baxter # 2B1357X - 0.45% Sodium Chloride and 20 mEq/L Potassium Chloride Injection, USP, 1000 ml, Viaflex Plastic Container, 14/cs (Rx) (Continental US Only, Excluding IN and ND)
Part Number Baxter 2B1357X
SKU Number CIA8043388
Sell Unit CASE
Ships Within Special Order
List Price $187.49
Enter a valid quantity
Product Description

Baxter 2B1357X - 0.45% Sodium Chloride and 20 mEq/L Potassium Chloride Injection, USP, 1000 ml, Viaflex Plastic Container, 14/cs (Rx) (Continental US Only, Excluding IN and ND)

Baxter 2B1357X 20 mEq/L Potassium Chloride in 0.45% Sodium Chloride Injection, USP, 1000 mL VIAFLEX Plastic Container

  • 20 mEq/L potassium chloride in 0.45% sodium chloride injection, usp
  • ViaFLEX plastic container, 1,000 mL
  • Potassium Chloride Injection Solution, 0.45%, 20 mEq / L, 1000 mL

Potassium Chloride in 0.45% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, solution for fluid and electrolyte replenishment in a single dose container for intravenous administration. It contains no antimicrobial agents. Composition, osmolarity, pH and ionic concentration are shown in table below.

20 mmol/L Potassium Chloride in
0.45% Sodium Chloride
Size (mL)Sodium Chloride, USP (NaCl)Potassium Chloride, USP (KCl)Osmolarity (m Osmol/L) (Calc.)
10004.51.5194
pHSodiumPotassiumChloride
5.5 (3.5 to 6.5)772097

Normal physiologic osmolarity range is approximately 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions (>600 mOsmol/L) may cause vein damage.

Potassium Chloride in 0.45% Sodium Chloride Injection, USP should be used with particular caution in patients on concomitant medications that may increase the risk of sodium and fluid retention, such as corticosteroids or corticotrophin.

Potassium Chloride in 0.45% Sodium Chloride Injection, USP should be administered with caution in patients treated on concomitant medications that increase the risk of hyponatremia such as diuretics, and certain antiepileptic and psychotropic medications.

Potassium Chloride in 0.45% Sodium Chloride Injection, USP in VIAFLEX Plus Plastic Container is available as follows:

The VIAFLEX Plus plastic container is fabricated from a specially formulated polyvinyl chloride (PL 146 Plastic). VIAFLEX Plus on the container indicates the presence of a drug additive in a drug vehicle. The VIAFLEX Plus plastic container system utilizes the same container as the VIAFLEX plastic container system. The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g., di-2-ethylhexyl phthalate (DEHP), up to 5 parts per million. However, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by tissue culture toxicity studies.

Related Products